Tetranectin (CLEC3B), a member of the C-type lectin domain family with importance in platelet biology (38), has already emerged as a marker of CAD; where levels were reduced in SAP patients in comparison to healthy controls (35, 39). Here, CLEC3B is linked to coronary artery disorder.